Inappropriate apoptosis of salivary and lacrimal gland epithelium of immunodeficient NOD-scid mice

Clinical and Experimental Rheumatology

Volumn 16, Issue 6, 1998, Pages 675-681

  Kong, L ^a   Robinson, C P ^b   Peck, A B ^b   Vela Roch, N ^a   Sakata, K M ^a   Dang, H ^a   Talal, N ^c   Humphreys Beher, M G ^b  

^a Mays Cancer Center at UT Health San Antonio   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

^c College of Physicians Surgeons ^*  (United States)

Author keywords

Fas (CD95); NOD scid, apoptosis; Salivary gland; Sjogren's syndrome

Indexed keywords

FAS ANTIGEN; FAS LIGAND;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; AUTOIMMUNE DISEASE; COMBINED IMMUNODEFICIENCY; CONTROLLED STUDY; LACRIMAL GLAND; LYMPHOCYTIC INFILTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SALIVARY GLAND; SCID MOUSE; SECRETORY CELL; SJOEGREN SYNDROME;

ANIMALS; ANTIGENS, CD95; APOPTOSIS; CELL COUNT; DNA PRIMERS; EPITHELIAL CELLS; FAS LIGAND PROTEIN; IMMUNOENZYME TECHNIQUES; IN SITU NICK-END LABELING; LACRIMAL APPARATUS; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED BALB C; MICE, INBRED NOD; MICE, SCID; RNA, MESSENGER; SALIVARY GLANDS; SJOGREN'S SYNDROME;

EID: 0031732757     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. WYLIE AH: The genetic regulation of apoptosis. Curr Opin Genetic Dev 1995;5:97-104.
2. KYRIAKIS JM, AVRUCH J: Sounding the alarm: Protein kinase cascades activated by stress and inflammation. J Biol Chem 1996; 271: 24313-6.
3. ANDERSON P: Kinase cascades regulating entry into apoptosis. Microbiol Molec Biol Rev 1997; 61: 33-46.
4. LIU X, ZOU H, SLAUGHTER C, WANG X: DFF, a heterodimeric protein that functions downstream of caspase-3 to trigger DNA fragmentation during apoptosis. Cell 1997; 89: 175-84.
5. WHITE E: Life, death and pursuit of apoptosis. Genes Dev 1996; 10: 1-15.
6. TAN EM: Autoimmunity and apoptosis. J Exp Med 1994; 179: 1083-6.
7. CASCIOLA-ROSEN LA, ANHALT G, ROSEN A: Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes. J Exp Med 1994; 179: 1317-30.
8. KONG L, OGAWA N, NAKABAYASHI T et al.: Fas and Fas ligand expression in the salivary glands of patients with primary Sjögren's syndrome. Arthritis Rheum 1997; 40: 87-97.
9. MANGANELLI P, QUAINI F, ANDREOLI AM et al.: Quantitative analysis of apoptosis and bcl-2 in Sjögren's syndrome. J Rheumatol 1997; 24: 1552-7.
10. CHERVONSKY AV, WANG Y, WONG FS, FLAVELL RA, JANEWAY CA Jr, MATIS LA: The role of Fas in autoimmune diabetes. Cell 1997; 89: 17-24.
11. GIORDANO C, STASSI G, DE MARIA R et al.: Potential involvement of Fas and its ligand in the pathogenesis of Hashimoto's thyroiditis. Science 1997; 275: 960-3.
12. ROBINSON CP, YAMACHIKA S, BRAYER J, PECK AB, HUMPHREYS-BEHER MG: A novel NOD-derived model for the study of primary Sjögren's syndrome. Arthritis Rheum 1998;41: 150-6.
13. ROBINSON CP, YAMAMOTO H, PECK AB, HUMPHREYS-BEHER MG: Genetically programmed development of salivary gland abnormalities in the NOD (nonobese diabetic)-scid mouse in the absence of detectable lymphocytic infiltration: A potential trigger for sialoadenitis in NOD mice. Clin Immunol Immunopathol 1996; 79: 50-9.
14. null mice reveals a role for autoantibodies in the loss of secretory function of exocrine tissues in Sjögren's syndrome. Proc Natl Acad Sci USA 1998; 95: 7538-43.
15. OGASAWARA J, WATANABE R, FUKUNAGA M et al.: Lethal effects of anti-Fas antibody in mice. Nature 1993; 364: 806-9.
16. ROBINSON CP, CORNELIUS J, BOUNOUS DI, YAMAMOTO H, HUMPHREYS-BEHER MG, PECK AB: Characterization of the changing lymphocyte populations and cytokine expression in the exocrine tissues of autoimmune NOD mice. Autoimmunity 1998; 27: 29-44.
17. GAVRIELI Y, SHERMAN Y, BEN-SASSON S: Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 1992; 119: 493-501.
18. SKARSTEIN K, NERLAND AH, EIDSHEIM M, MOUNTZ JD, JONSSON R: Lymphoid cell accumulation in salivary glands of autoimmune MRL mice can be due to impaired apoptosis. Scand J Immunol 1997; 46: 373-8.
19. BOLSTAD AI, JONSSON R: The role of apoptosis in Sjögren's syndrome. Annales Medecine Interne 1998; 149: 25-9.
20. ROBINSON CP, YAMACHIKA S, ALFORD CE et al.: Elevated levels of cysteine protease activity in the saliva and salivary glands of the nonobese diabetic (NOD) mouse model for Sjögren syndrome. Proc Natl Acad Sci (USA) 1997; 94: 5767-71.
21. PULKKI KJ: Cytokines and cardiomyocyte death. Ann Med 1997; 29: 339-43.
22. BROMME HJ, HOLTZ J: Apoptosis in the heart: When and why? Mol Cell Biochem 1996; 163: 261-275.
23. ITOH I, IMAGAWA A, HANAFUSA T et al.: Requirement of Fas for the development of autoimmune diabetes in non-obese diabetic mice. J Exp Med 1997; 186: 613-8.
24. BOUMBA D, SKOPOULI FN, MOUTSOPOULOS HM: Cytokine mRNA expression in the labial salivary gland tissues from patients with primary Sjögren's syndrome. Br J Rheumatol 1995; 34: 326-33.
25. MOUTSOPOULOS HM, KORDOSIS T: Sjögren's syndrome revisited: Autoimmune epithelitis. Br J Rheumatol 1996; 35: 204-6.
26. SUMIDA T, MATSUMOTO I, MURATA H et al.: TCR in Fas-sensitive T cells from the labial salivary glands of patients with Sjögren's syndrome. J Immunol 1997; 158: 1020-5.
27. GOISTEN P, MARGUET D, DEPRAETERE V: Fas bridging cell death and cytotoxicity: The reaper connection. Immunol Rev 1995; 146: 45-56.
28. LAU HT, YU M, FONTANA A, STOECKERT CJ Jr: Prevention of islet allograft rejection with engineered myoblasts expressing FasL in mice. Science 1995; 273: 109-12.
29. GRIFFITH TS, BRUNNER T, FLETCHER SM, GREEN DR, FERGUSON TA: Fas ligand-induced apoptosis as a mechanism of immune privilege. Science 1995; 270: 1189-92.
30. BELLGAU D: A role for CD 95 ligand in preventing graft rejection. Nature 1995; 377: 630-632.
31. SAAS P, WALKER PR, HAHNE M et al.: Fas ligand expression by astrocytoma in vivo: Maintaining immune privilege in the brain? J Clin Invest 1997; 99: 1173-8.
32. MIYAWAKI T, VEHARA T, NIBU R et al.: Differential expression of an apoptosis-related Fas antigen on lymphocyte subpopulations in human peripheral blood. J Immunol 1997; 149: 3753-8.
33. KIMURA K, ASAMI K, YAMAMOTO M: Structure for the promoter for the rat Fas antigen gene. Biochim Biophys Acta 1997; 1352: 238-42.
34. FUKUO K, HATA S, SUHARA T et al.: Nitric oxide induces upregulation of Fas and apoptosis in vascular smooth muscle. Hypertension 1996; 27: 823-6.
35. HANEJIN, NAKAMURA T, TAKIO K et al.: Identification of alpha-fodrin as a candidate autoantigen in primary Sjögren's syndrome. Science 1997; 276: 604-7.
36. BELL DA, MORRISON B, VANDEN-BYGAART B: Immunogenic DNA-related factors: Nucleosomes spontaneously released from normal murine lymphoid cells stimulate proliferation and immunoglobulin synthesis of normal mouse lymphocytes. J Clin Invest 1990; 85: 1487-96.
37. UTZ PJ, HOTTELET M, SCHUR PH, ANDERSON P: Proteins phosphorylated during stress-induced apoptosis are common targets for autoantibody production in patients with systemic lupus erythematosus. J Exp Med 1997; 185: 843-54.
38. GRABAR P: Hypothesis. Auto-antibodies and immunological theories: An analytical review. Clin Immunol Immunopathol 1975; 4: 453-66.
39. YAMAMOTO H, SIMS NE, MACAULEY SP, NGUYEN K-HT, NAKAGAWA Y, HUMPHREYS-BEHER MG: Alterations in the secretory response of non-obese diabetic (NOD) mice to muscarinic receptor stimulation. Clin Immunol Immunopathol 1996; 78: 245-55.
40. YAMAMOTO H, ISHIBASHI K, NAKAGAWA Y et al.: Detection of alterations in the levels of neuropeptides and salivary gland responses in the non-obese diabetic mouse model for autoimmune sialoadenitis. Scand J Immunol 1997; 45: 55-61.
41. HU Y, NAKAGAWA Y, WANG P-L, PURUSHOTHAM KR, HUMPHREYS-BEHER MG: Down-regulation of β-adrenergic receptors and signal transduction response in salivary glands of NOD mice. Am J Physiol 1994; 266: G433-G443.